C. Dasanu

发表

Tumor vaccines in 2010: need for integration.

S. Josephs, N. Riordan, E. Carrier, 2010, Cellular immunology.

Immunotherapy for Melanoma: Current Status and Perspectives

F. Marincola, A. Di Nardo, T. Ichim, 2010, Journal of immunotherapy.

Review article Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature

C. Dasanu, S. Atienza, J. Ann, 2012 .

Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature

C. Dasanu, J. Atienza, 2012, Current medical research and opinion.

Exogenous endothelial cells as accelerators of hematopoietic reconstitution

Amit N. Patel, T. Ichim, E. Woods, 2012, Journal of Translational Medicine.

Immune alterations and emerging immunotherapeutic approaches in lung cancer

C. Dasanu, Nishant Sethi, N. Ahmed, 2012, Expert opinion on biological therapy.

Bortezomib: friend or foe of hemolytic anemia?

C. Dasanu, 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations.

S. Majumder, C. Dasanu, Jose M. Soriano, 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

ACUTE LEUKEMIAS XV

C. Dasanu, B. Bockorny, 2015, Annals of Hematology.

Immune alterations and immunotherapy prospects in head and neck cancer

C. Dasanu, J. Atienza, Vincent Varilla, 2013, Expert opinion on biological therapy.

Autoimmune disorders in patients with T-cell lymphoma: a comprehensive review

C. Dasanu, M. Van den Bergh, A. Panwala, 2015, Current medical research and opinion.

Sustained clinico-radiologic response to anti-cytotoxic T lymphocyte antigen 4 antibody therapy in metastatic myxoid liposarcoma

C. Dasanu, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Pralatrexate: evaluation of clinical efficacy and toxicity in T-cell lymphoma

C. Dasanu, A. Shimanovsky, 2013, Expert opinion on pharmacotherapy.

Hair repigmentation associated with the use of lenalidomide: Graying may not be an irreversible process!

D. Alexandrescu, C. Dasanu, Demytra K Mitsis, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Primary squamous cell carcinoma of the thyroid with complete response to radical radiotherapy and concurrent cisplatin-based chemotherapy

Henry Tsai, C. Dasanu, M. D. Del Rosario, 2017, BMJ Case Reports.

Successful re-introduction of alectinib after inducing interstitial lung disease in a patient with lung cancer

C. Dasanu, A. Hwang, Andrew S Iskandar, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

A complex pattern of melanonychia and onycholysis after treatment with pemetrexed for lung cancer.

P. Wiernik, D. Alexandrescu, C. Dasanu, 2007, Skinmed.

Updates on immunotherapy in non-small cell lung cancer

C. Dasanu, A. Shimanovsky, 2014, Expert opinion on biological therapy.

H. pylori-Associated Gastric Cancer in a Husband-Wife Pair: A Veritable Family Affair

D. Alexandrescu, C. Dasanu, J. Rathmann, 2009, Southern medical journal.

Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization

Catherine B. Goff, C. Dasanu, Juliana Alvarez-Argote, 2022, Expert opinion on pharmacotherapy.

Cystic acne due to imatinib therapy for chronic myelocytic leukemia

C. Dasanu, M. D. Del Rosario, A. Hwang, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Generalized cerebral atrophy seen on MRI in a naturally exposed animal model for creutzfeldt-jakob disease

A. McKnight, T. Ichim, Gary Smith, 2010, Journal of Translational Medicine.

Clinico-epidemiologic characteristics and patterns of care in Kaposi’s sarcoma: Data from a single-institution series

Wesley T. Kerr, W. Kerr, C. Dasanu, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Immune alterations in untreated and treated multiple myeloma

C. Dasanu, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy

F. Marincola, J. Koropatnick, N. Riordan, 2014, Journal of Translational Medicine.

On the missing link between inflammation and cancer.

T. Ichim, N. Riordan, D. Alexandrescu, 2011, Dermatology online journal.

Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance☆

C. Dasanu, A. Shimanovsky, S. Murali, 2016, BBA clinical.

Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.

D. Alexandrescu, C. Dasanu, R. McClure, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia.

T. Ichim, N. Riordan, D. Alexandrescu, 2011, Dermatology online journal.

Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma

C. Dasanu, C. Yu, Yazeed Samara, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Newer developments in the immunotherapy of malignant melanoma

T. Ichim, D. Alexandrescu, C. Dasanu, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Management of advanced and/or metastatic carcinoid tumors: historical perspectives and emerging therapies

C. Dasanu, N. Nandy, 2013, Expert opinion on pharmacotherapy.

Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches

C. Dasanu, B. Bockorny, 2013, Expert opinion on biological therapy.

Late-onset pericardial tamponade, bilateral pleural effusions and recurrent immune monoarthritis induced by ipilimumab use for metastatic melanoma

R. Skulski, C. Dasanu, Tiffany Jen, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Newer developments in the therapeutics of the transitional cell carcinoma of renal pelvis

I. Codreanu, C. Dasanu, Aileen Ong-Bacay, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Emerging pharmacotherapeutic strategies for cholangiocarcinoma

G. Trikudanathan, S. Majumder, C. Dasanu, 2011, Expert opinion on pharmacotherapy.

BJRD13326 1..11

M. Robson, B. Jung, C. Holloway, 2013 .

mTOR-blocking agents in advanced renal cancer: an emerging therapeutic option

D. Alexandrescu, C. Dasanu, B. Clark, 2009 .

Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects!

A. Khurana, C. Dasanu, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?

T. Ichim, N. Riordan, J. Jackson, 2010, Panminerva Medica (Testo stampato).

Targeting macrophages in classical Hodgkin’s lymphoma may seem rational, but is it safe?

C. Dasanu, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Late-onset Stevens–Johnson syndrome due to nivolumab use for hepatocellular carcinoma

C. Dasanu, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy

C. Dasanu, A. Hwang, Andrew S Iskandar, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Plasmablastic haemato‐lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib

I. Codreanu, C. Dasanu, F. Bauer, 2013, Hematological oncology.

Immune alterations in untreated and treated myelodysplastic syndrome

C. Dasanu, P. Mewawalla, 2011, Expert opinion on drug safety.

Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature

I. Codreanu, C. Dasanu, B. Bockorny, 2012, British journal of haematology.

Risk of additional cancers in untreated and treated hairy cell leukemia patients

D. Alexandrescu, C. Dasanu, 2010, Expert opinion on pharmacotherapy.

Inherent and iatrogenic immune defects in hairy cell leukemia: revisited

T. Ichim, D. Alexandrescu, C. Dasanu, 2010, Expert opinion on drug safety.

Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy

C. Dasanu, J. Kaur, S. Tuler, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Synchronous gastric and ampullary adenocarcinomas in a hairy cell leukemia patient treated with pentostatin eight years prior

F. Senatore, C. Dasanu, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Subcutaneous panniculitis-like T-cell lymphoma in a patient with history of B-cell lymphoma treated successfully with chemotherapy 15 years prior

S. Gopal, C. Dasanu, J. Atienza, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice

C. Dasanu, 2008 .

Autoimmune manifestations in large granular lymphocyte leukemia.

C. Dasanu, B. Bockorny, 2012, Clinical lymphoma, myeloma & leukemia.

High-grade solitary extramedullary plasmacytoma arising in skeletal muscle of a kidney transplant recipient.

I. Codreanu, C. Dasanu, F. Bauer, 2011, Leukemia research.

Adenosquamous Carcinoma of the Pancreas: A Distinct Clinicopathologic Entity

G. Trikudanathan, C. Dasanu, 2010 .

Review article Vitamin B 12 deficiency in patients undergoing bariatric surgery: Preventive strategies and key recommendations

S. Majumder, C. Dasanu, Jose M. Soriano, 2013 .

Polycystic Ovary Syndrome: Focus on Platelets and Prothrombotic Risk

T. Ichim, D. Alexandrescu, C. Dasanu, 2011, Southern medical journal.

A curious case of a 'burned-out' hypereosinophilic syndrome.

C. Dasanu, F. Bauer, S. Cohen, 2011, Leukemia research.

Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine‐kinase inhibitors

D. Alexandrescu, C. Dasanu, J. Vaillant, 2006, Clinical and experimental dermatology.

Retroperitoneal fibrosis due to B-cell non-Hodgkin lymphoma: Responding to rituximab!

C. Dasanu, F. Bauer, A. Posteraro, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Persistent hair growth during treatment with the EGFR inhibitor erlotinib.

D. Alexandrescu, C. Dasanu, C. L. Kauffman, 2009, Dermatology online journal.

Relapsed refractory metastatic squamous cell cancer of anal canal in a patient with retroviral infection responding to cetuximab

C. Dasanu, Jaren Lerner, M. Michel, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.

N. Dawson, L. Wartofsky, D. Alexandrescu, 2008, Thyroid : official journal of the American Thyroid Association.

Gemcitabine: vascular toxicity and prothrombotic potential.

C. Dasanu, 2008, Expert opinion on drug safety.

Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide.

R. Schwartz, C. Dasanu, F. Bauer, 2011, Leukemia research.

Severe arthritic syndrome due to ibrutinib use for chronic lymphocytic leukemia

C. Dasanu, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Severe phototoxic reaction secondary to subcutaneous 5-azacitidine

C. Dasanu, M. Keating, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Fluorodeoxyglucose-induced allergic reaction: A case report

G. Weinstein, I. Codreanu, C. Divgi, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Development of squamous cell carcinomas in Darier disease: a new model for skin carcinogenesis?

D. Alexandrescu, C. Dasanu, C. L. Kauffman, 2008, The British journal of dermatology.

The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth?

D. Alexandrescu, C. Dasanu, C. L. Kauffman, 2009, Dermatology online journal.

Muehrcke’s lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia

T. Ichim, D. Alexandrescu, C. Dasanu, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Pyoderma gangrenosum due to lenalidomide use for multiple myeloma

D. Alexandrescu, C. Dasanu, B. Bockorny, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma.

D. Alexandrescu, C. Dasanu, J. Vaillant, 2006, Dermatology online journal.

Multiple myeloma and its therapies: to what extent do they contribute to the increased incidence of second malignant neoplasms?

C. Dasanu, P. Mewawalla, J. Grabska, 2012, Current medical research and opinion.

Merkel cell carcinoma: long-term follow-up of a single institution series and clinical outcomes by immunological status.

I. Codreanu, C. Dasanu, S. Plaxe, 2019, Dermatology online journal.

Normal values of regional and global myocardial wall motion in young and elderly individuals using navigator gated tissue phase mapping

M. Robson, B. Jung, C. Holloway, 2013, AGE.

Lasers, stem cells, and COPD

Amit N. Patel, S. Josephs, E. Carrier, 2010, Journal of Translational Medicine.

Hepatoid variant of pancreatic cancer: insights from a case and literature review.

S. Majumder, C. Dasanu, 2013, JOP : Journal of the pancreas.

Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?

D. Alexandrescu, C. Dasanu, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates

C. Dasanu, T. Rustagi, 2012, Journal of Gastrointestinal Cancer.

Kidney cancer therapy: new perspectives and avenues

D. Alexandrescu, C. Dasanu, 2006, Expert opinion on pharmacotherapy.

Bilateral Perinephric Diffuse Large B-Cell Lymphoma and Synchronous Renal Oncocytoma

D. Alexandrescu, C. Dasanu, 2008, Southern medical journal.

Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma

C. Dasanu, Antarpreet Kaur, 2011, Expert opinion on pharmacotherapy.

Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin’s lymphoma

C. Dasanu, T. Dang, Samir Macwan, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Immune alterations in malignant melanoma and current immunotherapy concepts

C. Dasanu, A. Shimanovsky, Ashif Jethava, 2013, Expert opinion on biological therapy.

Lemierre syndrome caused by group C streptococci and associated with red cell aplasia and immune thrombocytopenia.

C. Dasanu, F. Bauer, P. Mewawalla, 2011, Southern medical journal.

Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.

Fabian Lara, Amit N. Patel, Erik J Woods, 2010, Cellular immunology.

Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma?

D. Alexandrescu, C. Dasanu, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autoimmune phenomena in untreated and treated marginal zone lymphoma

C. Dasanu, J. Grabska, 2011, Expert opinion on pharmacotherapy.

Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma.

J. Dutcher, D. Alexandrescu, C. Dasanu, 2007, Southern medical journal.

Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer.

D. Alexandrescu, C. Dasanu, 2008, Southern medical journal.

Malignant melanoma in African-Americans.

D. Alexandrescu, C. Dasanu, F. Kabigting, 2009, Dermatology online journal.

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Michael J. González, J. Koropatnick, C. Chen, 2011, Journal of Translational Medicine.

Cardiovascular toxicity associated with small molecule tyrosine kinase inhibitors currently in clinical use

C. Dasanu, Christine Do, B. Clark, 2012, Expert opinion on drug safety.

Durvalumab in cancer medicine: a comprehensive review

C. Dasanu, Juliana Alvarez-Argote, 2019, Expert opinion on biological therapy.

Adult biphasic pulmonary blastoma.

C. Dasanu, Ashif Jethava, 2013, Connecticut medicine.

Collision tumors: pancreatic adenocarcinoma and mantle cell lymphoma.

D. Cooper, C. Dasanu, J. Atienza, 2013, JOP : Journal of the pancreas.

ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival

C. Dasanu, Juliana Alvarez Argote, 2018, Current medical research and opinion.

Necrotizing leg gangrene from invasive cutaneous Kaposi sarcoma, reversed by pegylated liposomal doxorubicin

D. Aboulafia, C. Dasanu, A. Stapleton, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?

I. Codreanu, O. Hamid, F. Limonadi, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Large granular lymphocytic (LGL) leukemia in an adult with Down syndrome (47,XX,+21).

C. Dasanu, F. Bauer, 2010, Leukemia research.

Gastrointestinal stromal tumor of small intestine and synchronous bilateral papillary renal cell carcinoma.

I. Codreanu, C. Dasanu, S. Ali, 2013, Connecticut medicine.

Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide.

C. Dasanu, F. Bauer, M. Reale, 2010, Leukemia research.

Association Between HBsAg Positivity and Pancreatic Cancer: a Meta-Analysis

W. Baker, S. Majumder, C. Dasanu, 2014, Journal of Gastrointestinal Cancer.

Functional 'composite' pheochromocytoma-ganglioneuroma presenting as a pancreatic mass.

G. Trikudanathan, S. Majumder, C. Dasanu, 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Acute gout flare of bilateral first metatarsophalangeal joints due to ibrutinib use in chronic lymphocytic leukemia

C. Dasanu, J. Kaur, S. Tuler, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Evolving therapeutic strategies for advanced hepatocellular carcinoma

C. Dasanu, A. Qureshi, Jaren Lerner, 2021, Expert opinion on pharmacotherapy.

Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: Is immunosuppression to blame?

C. Dasanu, B. Bockorny, R. Joseph, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Multidirectional pattern of hair growth with carflizomib use for multiple myeloma

C. Dasanu, J. Kaur, S. Tuler, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Erythematous skin lesions with necrotic centers on lower extremities due to the use of ruxolitinib for primary myelofibrosis

C. Dasanu, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Persistent foot ulcer due to ruxolitinib therapy for primary myelofibrosis

Henry Tsai, C. Dasanu, M. D. Del Rosario, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma

G. Trikudanathan, C. Dasanu, 2010, Expert opinion on pharmacotherapy.

Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs

I. Codreanu, F. Limonadi, C. Dasanu, 2019, Expert opinion on biological therapy.

Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia.

D. Alexandrescu, C. Dasanu, 2007, MedGenMed : Medscape general medicine.

Inflammatory and immune-related conditions associated with Waldenström macroglobulinemia: a single center experience

I. Codreanu, C. Dasanu, J. Atienza, 2015, Leukemia & lymphoma.

Cholangiocarcinoma and paraneoplastic hypercalcemia: a lethal combination revisited.

G. Trikudanathan, C. Dasanu, 2010, Southern medical journal.

Autoimmune disorders in patients with hairy cell leukemia: are they more common than previously thought?

C. Dasanu, M. Van den Bergh, Don Pepito, 2015, Current medical research and opinion.

Newer developments in adult T-cell leukemia/lymphoma therapeutics

C. Dasanu, 2011, Expert opinion on pharmacotherapy.

Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States

A. Cohen, M. Coleman, C. Farber, 2023, EJHaem.

A fatal disseminated cryptococcal infection in a patient treated with zanubrutinib for Waldenström’s macroglobulinemia

A. Stapleton, C. Dasanu, D. Patel, 2022, Journal of Oncology Pharmacy Practice.

Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors

G. Trikudanathan, S. Majumder, S. Gopal, 2012, Expert opinion on pharmacotherapy.

Syndrome of inappropriate antidiuretic hormone secretion due to marginal zone lymphoma: responding to rituximab.

C. Dasanu, B. Bockorny, 2012, Clinical Lymphoma, Myeloma & Leukemia.

Autoimmune manifestations in patients with Waldenström macroglobulinemia.

C. Dasanu, J. Atienza, B. Bockorny, 2014, Clinical lymphoma, myeloma & leukemia.

Autoimmune Manifestations in Patients With Waldenström

C. Dasanu, J. Atienza, B. Bockorny, 2022 .

Rapidly fatal acute ATLL emerging after methotrexate therapy for disseminated psoriasis.

T. Ichim, D. Alexandrescu, C. Dasanu, 2012, Clinical lymphoma, myeloma & leukemia.

Cecal volvulus associated with carfilzomib use for al amyloidosis.

C. Dasanu, J. Kaur, S. Tuler, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Prevalence of autoimmune hematologic and non-hematologic conditions in large granular lymphocytic leukemia: exploratory analysis of a series of consecutive patients

I. Codreanu, C. Dasanu, B. Bockorny, 2014, Leukemia & lymphoma.

Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis.

G. Trikudanathan, W. Baker, C. Dasanu, 2011, JOP : Journal of the pancreas.

Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice.

C. Dasanu, 2008, Expert opinion on pharmacotherapy.

Hepatitis associated aplastic anemia: case report and discussion.

A. Khurana, C. Dasanu, 2014, Connecticut medicine.

Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review

C. Dasanu, N. Nandy, 2013, Current medical research and opinion.

Recurrent pseudocellulitis due to gemcitabine: Underrecognized and underreported?

C. Dasanu, B. Bockorny, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Bluish-gray fingernail discoloration due to the use of nivolumab

C. Dasanu, Jaren Lerner, Miguel Michel Ocampo, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Malignant Melanoma in Pigmented Skin: Does the Current Interventional Model Fit a Different Clinical, Histologic, and Molecular Entity?

T. Ichim, D. Alexandrescu, C. Dasanu, 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Gemcitabine: vascular toxicity and prothrombotic potential

C. Dasanu, 2008 .

Acute Wernicke encephalopathy and sensorineural hearing loss complicating bariatric surgery.

C. Dasanu, Ashif Jethava, 2012, Connecticut medicine.

Monostotic Paget's disease involving the calcaneus encountered incidentally on bone scintigraphy.

I. Codreanu, Esther H. Lim, C. Dasanu, 2012, Foot.

Accelerated Premalignant Polyposis and Second Colon Cancers: Incriminating Immunosuppression, Radiotherapy, and Systemic Chemotherapy Agents

F. Senatore, C. Dasanu, S. Murali, 2016, Journal of Gastrointestinal Cancer.

A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma

C. Dasanu, Doru T. Alexandrescu, 2009, European journal of haematology.

Adenocarcinoma of the ampulla of Vater: What treatment options are available?

F. Senatore, C. Dasanu, M. L. Ynson, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Bilateral Leser-Trélat Sign Mirroring Lung Adenocarcinoma with Early Metastases to the Contralateral Lung

D. Alexandrescu, C. Dasanu, 2009, Southern medical journal.

Multicentric Neuroendocrine Carcinoma of the Breast Presenting with Multiple Osteolytic Bone Metastases.

Henry Tsai, C. Dasanu, M. D. Del Rosario, 2016, Connecticut medicine.

Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?

I. Codreanu, C. Dasanu, S. Plaxe, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Catastrophic arteriovenous thromboembolism as initial manifestation of pancreatic cancer.

S. Majumder, C. Dasanu, T. Thom, 2012, JOP : Journal of the pancreas.

IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?

F. Marincola, T. Ichim, N. Riordan, 2011, Journal of immunotherapy.

Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience.

I. Codreanu, C. Dasanu, J. Grabska, 2015, Connecticut medicine.

Rapidly progressive colonic dysplasia/neoplasia in a series of treated lung cancer patients: Is paclitaxel involved?

C. Dasanu, Antarpreet Kaur, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Synchronous Tumors: Adenosquamous Carcinoma of Pancreas and GIST of Stomach

G. Trikudanathan, C. Dasanu, T. Mesologites, 2011, Journal of gastrointestinal cancer.

Changing therapeutic landscape in advanced Kaposi sarcoma: Current state and future directions

Catherine B. Goff, C. Dasanu, C. Goff, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Complete heart block secondary to bortezomib use in multiple myeloma

C. Dasanu, 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Second primary pancreatic adenocarcinoma three years after successfully treated index esophageal cancer.

C. Dasanu, N. Nandy, 2014, JOP : Journal of the pancreas.

Strategy to reduce bortezomib-induced paralytic ileus in patients with myeloma and impaired renal function

C. Dasanu, M. Keating, 2016, BMJ Case Reports.

Chronic Lymphocytic Leukemia Presenting with Cholecystitis-Like Symptoms and Gallbladder Wall Invasion

T. Ichim, D. Alexandrescu, C. Dasanu, 2010, Southern medical journal.

A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage.

D. Alexandrescu, C. Dasanu, 2009, The American journal of the medical sciences.

Clinico-epidemiologic characteristics and patterns of care in Kaposi Sarcoma: Data from a single-institution series.

Wesley T. Kerr, C. Dasanu, S. Plaxe, 2018 .

Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?

I. Codreanu, C. Dasanu, S. Plaxe, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Acute retinal pigment epithelial detachment secondary to pamidronate administration

D. Alexandrescu, C. Dasanu, 2009, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

What are the latest pharmacotherapy options for small bowel adenocarcinoma?

F. Senatore, C. Dasanu, M. L. Ynson, 2014, Expert opinion on pharmacotherapy.

Widespread vitiligo and poliosis following ipilimumab–nivolumab combination therapy

C. Dasanu, A. Jamali, Khashayar Nemovi, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

A case of polycythemia rubra vera transforming into chronic phase JAK2 V617F mutation-negative Philadelphia chromosome-positive chronic myelogenous leukemia

C. Dasanu, F. Bauer, A. Shimanovsky, 2013, Leukemia & lymphoma.

Desmoid Tumor Mimicking GIST Recurrence

C. Dasanu, T. Mesologites, N. Nandy, 2014, Journal of Gastrointestinal Cancer.

Thrombocytopenia, NAFLD, and metabolic syndrome: is there a link?

G. Trikudanathan, C. Dasanu, Samuel Lamana, 2010, Southern medical journal.

Severe terminal ileitis induced by single-agent nivolumab administered every four weeks

Varun Gupta, C. Dasanu, S. Plaxe, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

An unusual presentation of a carcinoid tumor of the common bile duct.

C. Dasanu, T. Mesologites, V. Muralidharan, 2013, Journal of the Pancreas.

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

J. Sosman, A. Ribas, P. Scumpia, 2023, Nature Medicine.

HSOA Journal of Cardiology and Neurocardiovascular Diseases Comprehensive Assessment of Left Ventricular Wall Motion Abnormalities in Coronary Artery Disease Using Cardiac Magnetic Resonance

Ion Codreanu, M. Robson, C. Holloway, 2017 .

Effects of ventricular insertion sites on rotational motion of left ventricular segments studied by cardiac MR.

M. Robson, B. Jung, C. Holloway, 2013, The British journal of radiology.

Neuroblastoma with a Solitary Intraventricular Brain Metastasis Visualized on I‐123 MIBG Scan

H. Zhuang, I. Codreanu, C. Dasanu, 2014, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Immune checkpoint inhibition in advanced colorectal cancer with inherited and acquired microsatellite instability: Current state and future directions.

I. Codreanu, S. Habibi, C. Dasanu, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out

M. Robson, B. Jung, C. Holloway, 2011, Vascular health and risk management.

Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer

S. Lippman, C. Dasanu, S. Plaxe, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab

C. Dasanu, A. Hwang, Andrew S Iskandar, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Respiratory failure due to lung involvement with adult T-cell leukemia/lymphoma: case report and review of literature.

C. Dasanu, M. Shah, A. Vyas, 2014, Connecticut medicine.

Advanced papillary thyroid carcinoma responding to nivolumab

C. Dasanu, Jaren Lerner, S. Tosonian, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Small Cell Lung Cancer with Paraneoplastic Lipase Production

T. Ichim, B. Lahiri, D. Alexandrescu, 2010, Southern medical journal.

Cures with B-Raf inhibitors as single agents in metastatic B-Raf mutated melanoma: Curb your enthusiasm?

C. Dasanu, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Carboplatin—gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration

T. Herzog, D. Alexandrescu, C. Dasanu, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Angioedema late in the course of adjuvant nivolumab therapy for melanoma

C. Dasanu, A. Ratra, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Peripheral blood immunophenotypic analysis as a diagnostic tool for large granular lymphocyte leukemia

M. Conlon, C. Dasanu, B. Bockorny, 2013, Leukemia and Lymphoma.

5-azacitidine reversing “spent” phase polycythemia vera back to proliferative phase and need for phlebotomy

C. Dasanu, Jaren Lerner, M. Michel, 2020, Journal of Oncology Pharmacy Practice.

Immune checkpoint inhibitor-related adverse events: Real-world experience from a single veterans' affairs medical center.

C. Dasanu, Juliana Alvarez-Argote, K. Sherman, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

ACUTE LEUKEMIAS XV

A. Trumpp, C. Dasanu, W. Hofmann, 2015, Annals of Hematology.

Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST.

D. Alexandrescu, C. Dasanu, H. Farzanmehr, 2008, Dermatology online journal.

Multiple myeloma and its therapies: to what extent do they contribute to the increased incidence of second malignant neoplasms?

C. Dasanu, P. Mewawalla, J. Grabska, 2012, Current medical research and opinion.

Bevacizumab in lung cancer: Lackluster performance and unjustified expense?

C. Dasanu, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Hyperviscosity syndrome in a patient with kappa light chain myeloma with cryoglobulin properties and alpha thalassemia.

Ari B. Geller, C. Dasanu, P. Mewawalla, 2010, Leukemia research.